Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pexiganan cream for mild diabetic foot ulcer infections (OneStep-2)
NCT01594762Phase 3Completed
- Sponsor
- Dipexium Pharmaceuticals, Inc.
- Start
- Jun 2014
- Primary completion
- Jul 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pexiganan in diabetic foot infection (DFI), sponsored by Dipexium Pharmaceuticals, Inc.. Started Jun 2014; status: completed.
02
Drugs
pexiganan
03
Conditions
diabetic foot infection (DFI)
Beyond the preview
Go deeper on NCT01594762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01594762.